Exane Derivatives’s PIMCO Corporate & Income Strategy Fund PCN Stock Holding History

Exane Derivatives’s Portfolio PCN Stock Details PCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,700	Closed	-$26.8K	–	885
2022 Q1	$26.8K	Hold	1,700	–	–	0.01%	636
2021 Q4	$29.1K	Hold	1,700	–	–	0.01%	549
2021 Q3	$30.7K	Hold	1,700	–	–	0.01%	663
2021 Q2	$32K	Hold	1,700	–	–	0.01%	680
2021 Q1	$29.4K	Hold	1,700	–	–	0.01%	548
2020 Q4	$29.3K	Hold	1,700	–	–	0.01%	498
2020 Q3	$26.5K	Sell	1,700 -21,500	-93%	-$339K	0.01%	410
2020 Q2	$367K	Sell	23,200 -16,800	-42%	-$253K	0.1%	178
2020 Q1	$534K	Hold	40,000	–	–	0.15%	119
2019 Q4	$785K	Hold	40,000	–	–	0.15%	117
2019 Q3	$734K	Buy	+40,000	New	+$713K	0.13%	125

Other funds holding PCN

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Bridge Advisory Pasadena, California $210M AUM 21.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Exane Derivatives's PCN Position: Q2 2022 in Review

Exane Derivatives sold out of PIMCO Corporate & Income Strategy Fund (PCN) in Q2 2022, closing a stake of 1,700 shares — an estimated $26.8K sold.

Exane Derivatives first reported a position in PCN in Q3 2019 and held it in 11 quarters. The position peaked at $785K in Q4 2019. 77 funds tracked by Wall St. Rank hold PCN as of Q2 2022.

Exane Derivatives reported no remaining PIMCO Corporate & Income Strategy Fund position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 1,700 PIMCO Corporate & Income Strategy Fund shares in Q2 2022, an estimated $26.8K.
Exane Derivatives first reported a position in PIMCO Corporate & Income Strategy Fund in Q3 2019 and held it in 11 quarters.
Exane Derivatives's PIMCO Corporate & Income Strategy Fund position peaked at $785K in Q4 2019.
77 funds tracked by Wall St. Rank held PIMCO Corporate & Income Strategy Fund as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.